By leveraging their unique physicochemical properties, including high bioavailability and relatively low toxicity, these nanoparticles were shown to effectively counteract the cellular damage associated with drug-induced hepatotoxicity. The study, conducted using both human normal hepatocyte L-02 cells and an acute liver injury mouse model, demonstrates that the intervention acts through a multifaceted mechanism involving the regulation of oxidative stress, inflammation, and ferroptosis.
The study aimed to investigate the protective efficacy and mechanistic basis of biosynthesized selenium nanoparticles against acetaminophen-induced acute liver injury.
The experimental approach included a detailed analysis of hepatic oxidative stress markers, specifically examining glutathione levels, total superoxide dismutase activity, and malondialdehyde concentrations. In the mouse model, the administration of selenium nanoparticles was found to markedly mitigate hepatic necrosis and reduce inflammatory cell infiltration. These observations were supported by serum analysis, which revealed that treated subjects experienced normalized liver indices and significantly reduced levels of alanine aminotransferase and aspartate aminotransferase compared to the untreated acetaminophen-intoxicated controls.
Mechanistically, the protective effects of selenium nanoparticles are rooted in their ability to restore the balance of iron metabolism and lipid peroxidation processes. The study observed that the particles reversed the downregulation of glutathione peroxidase 4, a key regulator of ferroptosis, while simultaneously modulating the expression of several iron metabolism-related genes. These included the transferrin receptor, ferritin heavy and light chains, ferroportin, and heme oxygenase 1, which together helped to diminish intracellular ferrous iron accumulation and lipid peroxidation within the hepatocytes.
The modulation of the inflammatory response also played a critical role in the observed hepatoprotection. The research highlighted that selenium nanoparticles effectively suppressed the expression of several pro-inflammatory cytokines, including interleukin-6, interleukin-1 beta, tumor necrosis factor-alpha, and various chemokines such as CCL5, CXCL2, and CXCL10.
These findings provide a solid experimental foundation for the further development of selenium-based nanomaterials as therapeutic agents for liver injury.
Subject of Research: Hepatoprotective mechanism of selenium nanoparticles in acetaminophen-induced liver injury
Article Title: Selenium nanoparticles confer protection against acetaminophen hepatotoxicity by attenuating oxidative stress, inflammation, and ferroptosis
Article References: Pan, X., Xia, W., Fang, X., Zhang, Z., Chen, X., Wu, Z., Yang, Y., Zhang, Z., Luo, K., Zhou, C., Li, D., & Huang, C. (2026). Selenium nanoparticles confer protection against acetaminophen hepatotoxicity by attenuating oxidative stress, inflammation, and ferroptosis. International Journal of Emergency Medicine. https://doi.org/10.1186/s12245-026-01375-y
Image Credits: AI Generated
DOI: 10.1186/s12245-026-01375-y
Keywords: Selenium nanoparticles, Acetaminophen, Hepatotoxicity, Ferroptosis, Oxidative stress, Inflammation, Liver injury, GPX4, Iron metabolism, Pharmacology, Nanomedicine, Hepatocytes, Cytoprotection, Drug-induced liver injury, Antioxidants
News Source: Ophelia Keating. (November 19, 2026). Selenium Nanoparticles Mitigate Acetaminophen-Induced Liver Injury by Blocking Ferroptosis. Scienmag.



